News
Rotablation aids in prepping highly calcified lesions: PREPARE-CALC
SAN DIEGO – Preparatory rotational atherectomy’s early edge over modified balloon may not last.
News
Prosthesis-patient mismatch post TAVR ups death risk 19%
SAN DIEGO – About one in eight patients have severe PPM after undergoing TAVR, according to the largest study to date of this population.
News
Drug-coated stent bests bare metal in patients with high bleeding risk
SAN DIEGO – Positive
News
Study sheds new light on prognostic factors in PRCC
PRCC subtypes 1 and 2 have differing histologic features and immunohistochemical profiles, but subtype does not independently predict overall...
News
Meta-analysis supports rituximab maintenance in MCL
Rituximab maintenance therapy prolonged progression-free survival. Risk of grade 3 or 4 neutropenia was increased, but risk of infection was not...
News
Auto-HSCT linked to higher AML, MDS risk
Patients undergoing autologous hematopoietic stem cell transplant (auto-HSCT) for lymphoma or myeloma have an increased risk of acute myeloid...
News
Autotransplant is linked to higher AML, MDS risk
For patients with lymphoma or plasma cell myeloma, autologous hematopoietic cell transplantation was linked to marked increases in the risk of AML...
Article
Broad genomic testing of NSCLC in community oncology disappoints
Among patients with advanced NSCLC treated in community oncology practices, broad-based genomic sequencing seldom exclusively informed the...
News
Trio of biosimilars have good showing
CHICAGO – Biosimilars for three widely used oncology drugs showed efficacy and safety similar to those of the reference products in lung cancer...
News
Trastuzumab biosimilar is equivalent on central review
CHICAGO – In a 20-country neoadjuvant trial, findings when tissue was centrally reviewed differed somewhat from those when tissue was reviewed...
News
Youth with rhabdomyosarcoma see better survival with maintenance chemo
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
News
New cell-free DNA assays hold promise for lung cancer screening
CHICAGO – Three blood-based assays for circulating cell-free DNA detected lung cancer of stage I-IIIA had sensitivities of 38%-51% and...
News
H&N cancer may be undertreated in women
CHICAGO – Female patients with H&N cancer had almost twice the ratio of cancer deaths to noncancer deaths.
News
TAILORx marks major advance for precision medicine in breast cancer
CHICAGO – Practice-changing data show that most women with HR-positive, HER2-negative, early-stage breast cancer who have an intermediate...
Video
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate...